Detalles de la búsqueda
1.
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG).
Oncologist
; 28(10): e877-e883, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310797
2.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721561
3.
Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.
Br J Cancer
; 125(10): 1356-1364, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480095
4.
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.
Br J Cancer
; 120(9): 913-921, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30899086
5.
Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.
Clin Exp Rheumatol
; 34(3): 489-99, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26966919
6.
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.
BMC Musculoskelet Disord
; 16: 176, 2015 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-26228643
7.
Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.
BMC Musculoskelet Disord
; 15: 14, 2014 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-24410774
8.
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature.
J Clin Oncol
; 42(10): 1124-1134, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241603
9.
Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort.
Breast
; 71: 143-149, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37225592
10.
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy.
J Clin Oncol
; 41(16): 2988-2997, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36977286
11.
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
J Clin Oncol
; 41(16): 2998-3008, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37075276
12.
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial.
J Clin Oncol
; 41(12): 2159-2165, 2023 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36383926
13.
Obesity-associated changes in molecular biology of primary breast cancer.
Nat Commun
; 14(1): 4418, 2023 07 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37479706
14.
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression.
Breast
; 64: 100-111, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636341
15.
Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.
J Clin Oncol
; 40(12): 1335-1345, 2022 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35061525
16.
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.
J Geriatr Oncol
; 13(5): 582-593, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101364
17.
Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study.
Ann Rheum Dis
; 70(11): 2003-7, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21914628
18.
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study.
Clin Cancer Res
; 27(20): 5482-5491, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301749
19.
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.
NPJ Breast Cancer
; 7(1): 98, 2021 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34312396
20.
Are joint and soft tissue injections painful? Results of a national French cross-sectional study of procedural pain in rheumatological practice.
BMC Musculoskelet Disord
; 11: 16, 2010 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20100351